Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +15.83%
#4 Fabric Protocol Fabric Protocol +10.45%
#5 Perle Perle +8.39%
#6 Bedrock Bedrock +7.48%
#7 Cap Cap +4.08%
#8 BOOK OF MEME BOOK OF MEME +3.93%
#9 Dual Dual +3.60%
#10 stake.link stake.link +3.56%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Anatara Lifesciences Ltd Anatara Lifesciences Ltd

Anatara Lifesciences Ltd

ANR
Rang in Aktien #37961
Anatara Lifesciences Ltd is an Australian enterprise focused on researching,... Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals. Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water. This company was founded in 2010 and is headquartered in Carlton, Australia.
Aktienkurs
$0.00634756
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$1.32M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
39.40%
Land
AU
Handel Anatara Lifesciences Ltd (ANR)

Kategorie

Healthcare
EPS für Anatara Lifesciences Ltd (ANR)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Anatara Lifesciences Ltd beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Anatara Lifesciences Ltd von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE